Overview
Joseph Muenzer is a Pediatrics provider in Chapel Hill, North Carolina. Dr. Muenzer is rated as an Advanced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Dr. Muenzer is currently accepting new patients.
His clinical research consists of co-authoring 68 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Children's Health Center Neonatal Cardiac Development Clinic
I am a neonatologist with a specialized interest in post-hospitalization care for infants. My clinical time is spent across various environments including the Intensive Care Nursery, Transitional Care Nursery, and the Special Infant Care Clinic, ensuring continuity of care for the most vulnerable patients and supporting families during this pivotal time. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. Her top areas of expertise are Carnitine Palmitoyltransferase 2 Deficiency, Newborn Low Blood Sugar, High Blood Pressure in Infants, and Bronchopulmonary Dysplasia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mucopolysaccharidoses (MPS)Dr. Muenzer isElite. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Distinguished
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)
- Advanced
- Carnitine Palmitoyltransferase 1 Deficiency
- Carnitine Palmitoyltransferase 2 Deficiency
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- Sudden Infant Death Syndrome (SIDS)Dr. Muenzer isAdvanced. Learn about Sudden Infant Death Syndrome (SIDS).
- Experienced
- Brachydactyly Mononen TypeDr. Muenzer isExperienced. Learn about Brachydactyly Mononen Type.
- Exocrine Pancreatic InsufficiencyDr. Muenzer isExperienced. Learn about Exocrine Pancreatic Insufficiency.
- Gaucher DiseaseDr. Muenzer isExperienced. Learn about Gaucher Disease.
- Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
- Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)
- Phenylketonuria (PKU)Dr. Muenzer isExperienced. Learn about Phenylketonuria (PKU).